PR71
POST REGISTRATION ACTION MAILED - SEC.71
08/12/2026
Back to search
Official data from USPTO
PENTAMBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/12/2026
Trademark type
Word
Nice classes
5
Filing date
06/29/2017
Registration date
11/05/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2019
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Beijing, CN
Examiner
JOHN, CRISTEL M
Current location
Historical data usage
Holders and representatives
Holders
BEIJING HANMI PHARMACEUTICAL CO., LTD.
Representatives
Kenneth A. Knox Perilla Knox & Hildebrandt LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposespharmaceutical preparationsdrugs for medical purposesbiological preparations for medical purposesbiochemical drugspharmaceutical preparations in the form of injectioneach of which beingfor treating one or more of autoimmune diseasesimmune response against graftsallergic reactionsneurodegenerative diseasesneoplastic diseases and cellular proliferative disordersarthritisrheumatoid arthritispsoriasismultiple sclerosis (MS)ulcerative colitisCrohn's diseasesystemic lupus erythematosus (SLE)glomerulonephritisdilated cardiomyopathy-like diseasesSjogren's syndromeallergic contact dermatitispolymyositissclerodermaperiarteritis nodosarheumatic fevervitiligoinsulin-dependent diabetes mellitusBehcet's syndromechronic thyroiditisParkinson's diseaseHuntington's diseaseMachado-Joseph diseaseamyotrophic lateral sclerosis (ALS)Creutzfeldt - Jakob diseaseleukemialymphomamyelomabrain tumorshead and neck squamous cell carcinomanon-small cell lung cancer (NSCLC)nasopharyngeal canceresophageal cancerstomach cancerpancreatic cancergallbladder cancerliver cancercolorectal cancerbreast cancerovarian cancercervical cancerendometrial canceruterine sarcomaprostate cancerbladder cancerrenal cell carcinomamelanomacombinations thereof; nutritional supplements and dietetic substances adapted for medical usedietetic foods adapted for medical use and dietetic beverages adapted for medical use
Publications
History of USPTO decisions and trademark events.
47 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2026
ES71
TEAS SECTION 71 RECEIVED
04/30/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/24/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/02/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
03/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2019
PUBO
PUBLISHED FOR OPPOSITION
08/20/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/31/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/31/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/19/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/19/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/17/2019
EXPI
EX PARTE APPEAL-INSTITUTED
06/17/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/17/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
06/17/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/17/2018
GNFR
FINAL REFUSAL E-MAILED
12/17/2018
CNFR
FINAL REFUSAL WRITTEN
12/17/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/14/2018
ALIE
ASSIGNED TO LIE
11/09/2018
NREV
NOTICE OF REVIVAL - MAILED
10/31/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2018
PETG
PETITION TO REVIVE-GRANTED
10/30/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
10/30/2018
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
10/01/2018
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
10/01/2018
RFNT
REFUSAL PROCESSED BY IB
02/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/03/2018
RFRR
REFUSAL PROCESSED BY MPU
02/02/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/29/2018
CNRT
NON-FINAL ACTION WRITTEN
01/28/2018
MAFR
APPLICATION FILING RECEIPT MAILED
01/23/2018
DOCK
ASSIGNED TO EXAMINER
01/19/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/18/2018
Continuous trademark protection
Get notified about every new filing that threatens PENTAMBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.